Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction.
作者： Wen-Ping Wang , Kang-Ning Wang , Qiang Gao , Long-Qi Chen
关键词:
摘要: Background The epidermal growth factor receptor (EGFR) inhibitor, gefitinib, has been reported to successfully treat advanced non-small cell lung cancer patients with genetic mutations in EGFR. The aim of this study was investigate the existence EGFR carcinoma esophagogastric junction, and also explore possibility treating junction using gefitinib.
biomedcentral.com
springer.com
paperity.org参考文章(20)
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, Thomas J. Lynch, Jr, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, Harris Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael K. Wolf, Steven D. Averbuch, Judith J. Ochs, Andrea C. Kay, Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial JAMA. ,vol. 290, pp. 2149- 2158 ,(2003) , 10.1001/JAMA.290.16.2149
Maarten L. Janmaat, Mariëlle I. Gallegos-Ruiz, José A. Rodriguez, Gerrit A. Meijer, Walter L. Vervenne, Dick J. Richel, Cees Van Groeningen, Giuseppe Giaccone, Predictive Factors for Outcome in a Phase II Study of Gefitinib in Second-Line Treatment of Advanced Esophageal Cancer Patients Journal of Clinical Oncology. ,vol. 24, pp. 1612- 1619 ,(2006) , 10.1200/JCO.2005.03.4900
J Guillermo Paez, Pasi A Janne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J Eck, William R Sellers, Bruce E Johnson, Matthew Meyerson, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. ,vol. 304, pp. 1497- 1500 ,(2004) , 10.1126/SCIENCE.1099314
Martin H. Cohen, Grant A. Williams, Rajeshwari Sridhara, Gang Chen, W. David McGuinn, David Morse, Sophia Abraham, Atiqur Rahman, Chenyi Liang, Richard Lostritto, Amy Baird, Richard Pazdur, United States Food and Drug Administration Drug Approval Summary: Gefitinib (ZD1839; Iressa) Tablets Clinical Cancer Research. ,vol. 10, pp. 1212- 1218 ,(2004) , 10.1158/1078-0432.CCR-03-0564
Wei Gongquan, Surgical treatment of carcinoma of the esophagus and gastric cardia: 34-year investigation Chiese Journal of Surgery. ,(2001)
WQ Chen, SW Zhang, ZF Chen, An Epidemiologic Trend Analysis on Cardiac Cancer in High Incidence Areas of Esophageal Cancer and Gastric Cancer in China China Cancer. ,(2008)
John Mendelsohn, Targeting the epidermal growth factor receptor for cancer therapy. Journal of Clinical Oncology. ,vol. 20, ,(2002)
Xue-Ning Yang, Jian Su, Chong-Rui Xu, Yu-Juan Huang, Jin-Ji Yang, Xu-Chao Zhang, Yi-Sheng Huang, Yi-Long Wu, Zhen Wang, Qing Zhou, Impact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancer. Chinese Medical Journal. ,vol. 124, pp. 2457- ,(2011)
Lin Cui, Xin-Min Pan, Chun-Fen Ma, Jun Shang-Guan, Hai-Bin Yu, Guang-Xue Chen, Jia Wang, Association Between Epidermal Growth Factor Polymorphism and Esophageal Squamous Cell Carcinoma Susceptibility Digestive Diseases and Sciences. ,vol. 55, pp. 40- 45 ,(2010) , 10.1007/S10620-008-0700-5
Jin Eun Choi, Sun Ha Park, Kyung Mee Kim, Won Kee Lee, Sin Kam, Sung Ick Cha, Chang Ho Kim, Young Mo Kang, Young-Chul Kim, Sung Beom Han, Tae Hoon Jung, Jae Yong Park, Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study BMC Cancer. ,vol. 7, pp. 199- 199 ,(2007) , 10.1186/1471-2407-7-199